Region: WEL Atlantic
Nucliq Biologics
ScotiaDerm
Verlo
Myomar Molecular
Women’s Equity Lab Atlantic Investment group launches 2nd fund to boost investment in Women-Led Businesses
July 2024 — The Women’s Equity Lab Atlantic Investment Group (WEL Atlantic) is proud to announce the launch of its 2nd fund to continue its mission to support women-led businesses and build the community of female investors. With an impressive growth in Limited Partners (LPs) WEL Atlantic’s 2nd fund has 50 women investors.
WEL Atlantic has successfully raised $250,000 to invest in women-led businesses across the Atlantic provinces. This initiative underscores WEL’s commitment to creating opportunities for local companies while also cultivating a new generation of women investors. Continue reading “Women’s Equity Lab Atlantic Investment group launches 2nd fund to boost investment in Women-Led Businesses”